Patent Application
Utility
App. No. 16/656,022
· Confirmation No. 5457
Naltrexone Long Acting Formulations and Methods of Use
Inventor:
Elliot Ehrich
Applicant:
Alkermes Pharma Ireland Limited
Abandoned -- Incomplete Application (Pre-examination)
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2020-04-14 | ABN |
Abandonment | 1 | View | |
| 2020-04-14 | ABN |
Abandonment | 1 | View | |
| 2020-04-09 | EABN |
Letter Express Abandonment of the application | 1 | View | |
| 2020-04-09 | XT/ |
Extension of Time | 1 | View | |
| 2020-04-09 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-04-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-11-05 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2019-11-05 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-11-05 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-10-17 | PA.. |
Power of Attorney | 1 | View | |
| 2019-10-17 | OATH |
Oath or Declaration filed | 1 | View | |
| 2019-10-17 | TRNA |
Transmittal of New Application | 1 | View | |
| 2019-10-17 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-10-17 | ADS |
Application Data Sheet | 8 | View | |
| 2019-10-17 | ABST |
Abstract | 1 | View | |
| 2019-10-17 | CLM |
Claims | 3 | View | |
| 2019-10-17 | SPEC |
Specification | 27 | View | |
| 2019-10-17 | DRW.NONBW |
Drawings-other than black and white line drawings | 5 | View | |
| 2019-10-17 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2019-10-17 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Elliot Ehrich
Boston, MA
Attorneys & Agents of Record
Classification
USPC
514/282
Prosecution
- Art Unit
- 1629
- Customer No.
- 38421
- Docket No.
- 4165.3010 US9
- Confirmation No.
- 5457
Parent
is a Continuation of
→
App. 16/565,907
Filed 2019-09-10
· Expressly Abandoned -- During Examination
Parent
is a Continuation of
→
App. 16/251,542
Filed 2019-01-18
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/107,218
Filed 2018-08-21
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 15/486,869
Filed 2017-04-13
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/254,580
Filed 2016-09-01
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 13/871,534
Filed 2013-04-26
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 13/037,713
Filed 2011-03-01
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Division of
→
App. 11/083,167
· US 7,919,499
Filed 2005-03-17
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/564,542
Filed 2004-04-22
· Provisional Application Expired
Child
is a Continuation of
→
App. 17/244,110
Filed 2021-04-29
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 16/844,020
Filed 2020-04-09
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/540,490
Filed 2021-12-02
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/861,575
Filed 2022-07-11
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/243,832
Filed 2023-09-08
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/070,173
Filed 2020-10-14
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/099,645
· Abandoned -- Incomplete Application (Pre-examination)
RELEASE OF PATENT SECURITY AGREEMENTS
Recorded 2024-12-24
SECURITY INTEREST
Recorded 2020-03-20
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/656,022
- Filed
- 2019-10-17
- Art Unit
- 1629
External Links